News + Filings Transactions
|
Mahmoud Ramy A
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
03/16/2023 | OptiNose, Inc. | OPTN | Sale | Common Stock | 11k | $1.79 | $19.8k | | 03/15/2023 |
03/15/2023 | OptiNose, Inc. | OPTN | Grant | Common Stock | 6.1k | $0.00 | $0 | | 03/15/2023 |
01/30/2023 | OptiNose, Inc. | OPTN | Grant | Common Stock | 336.1k | $0.00 | $0 | | 01/30/2023 |
01/30/2023 | OptiNose, Inc. | OPTN | Grant | Stock Option (Right to Buy) | 549.2k | $1.74 | $955.6k | | 01/30/2023 |
01/13/2023 | OptiNose, Inc. | OPTN | Sale | Common Stock | 8.1k | $0.00 | $0 | | 01/13/2023 |
12/15/2022 | OptiNose, Inc. | OPTN | Grant | Common Stock | 6.1k | $0.00 | $0 | | 12/15/2022 |
12/15/2022 | OptiNose, Inc. | OPTN | Sale | Common Stock | 7.5k | $0.00 | $0 | | 12/15/2022 |
09/20/2022 | OptiNose, Inc. | OPTN | Sale | Common Stock | 2.9k | $3.56 | $10.5k | | 09/15/2022 |
09/16/2022 | OptiNose, Inc. | OPTN | Sale | Common Stock | 23.7k | $3.55 | $84k | | 09/15/2022 |
09/15/2022 | OptiNose, Inc. | OPTN | Grant | Common Stock | 6.1k | $0.00 | $0 | | 09/15/2022 |
06/16/2022 | OptiNose, Inc. | OPTN | Sale | Common Stock | 28.1k | $3.49 | $98k | | 06/15/2022 |
06/15/2022 | OptiNose, Inc. | OPTN | Grant | Common Stock | 48.9k | $0.00 | $0 | | 06/15/2022 |
03/16/2022 | OptiNose, Inc. | OPTN | Sale | Common Stock | 8.2k | $2.11 | $17.3k | | 03/16/2022 |
01/11/2022 | OptiNose, Inc. | OPTN | Grant | Common Stock | 59.2k | $0.00 | $0 | | 01/11/2022 |
01/11/2022 | OptiNose, Inc. | OPTN | Grant | Stock Option (Right to Buy) | 88.8k | $1.85 | $164.3k | | 01/11/2022 |
01/11/2022 | OptiNose, Inc. | OPTN | Grant | Stock Option (Right to Buy) | 172.4k | $1.85 | $319k | | 01/11/2022 |
12/16/2021 | OptiNose, Inc. | OPTN | Sale | Common Stock | 916 | $1.64 | $1.5k | | 12/16/2021 |
06/17/2021 | OptiNose, Inc. | OPTN | Sale | Common Stock | 909 | $3.73 | $3.4k | | 06/17/2021 |
03/15/2021 | OptiNose, Inc. | OPTN | Sale | Common Stock | 3.6k | $3.92 | $14.3k | | 03/15/2021 |
03/04/2021 | OptiNose, Inc. | OPTN | Grant | Common Stock | 100k | $0.00 | $0 | | 03/04/2021 |
03/04/2021 | OptiNose, Inc. | OPTN | Grant | Stock Option (Right to Buy) | 150k | $3.51 | $526.5k | | 03/04/2021 |
12/23/2020 | OptiNose, Inc. | OPTN | Sale | Common Stock | 23.4k | $4.03 | $94.5k | | 12/23/2020 |
12/23/2020 | OptiNose, Inc. | OPTN | Payment of Exercise | Common Stock | 34k | $4.03 | $137.2k | | 12/23/2020 |
12/23/2020 | OptiNose, Inc. | OPTN | Sale | Common Stock | 7.8k | $4.03 | $31.6k | By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud | 12/23/2020 |
12/23/2020 | OptiNose, Inc. | OPTN | Payment of Exercise | Common Stock | 11k | $4.03 | $44.4k | By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud | 12/23/2020 |
12/23/2020 | OptiNose, Inc. | OPTN | Exercise | Stock Option (Right to Buy) | 85k | $1.63 | $138.6k | | 12/23/2020 |
12/23/2020 | OptiNose, Inc. | OPTN | Exercise | Stock Option (Right to Buy) | 28.3k | $1.63 | $46.2k | By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud | 12/23/2020 |
11/25/2020 | OptiNose, Inc. | OPTN | Sale | Common Stock | 2.9k | $4.32 | $12.6k | | 11/23/2020 |
11/25/2020 | OptiNose, Inc. | OPTN | Payment of Exercise | Common Stock | 4k | $4.32 | $17.2k | | 11/23/2020 |
11/25/2020 | OptiNose, Inc. | OPTN | Sale | Common Stock | 977 | $4.32 | $4.2k | By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud | 11/23/2020 |
11/25/2020 | OptiNose, Inc. | OPTN | Payment of Exercise | Common Stock | 1.3k | $4.32 | $5.7k | By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud | 11/23/2020 |
11/25/2020 | OptiNose, Inc. | OPTN | Exercise | Stock Option (Right to Buy) | 10.5k | $1.63 | $17.1k | | 11/23/2020 |
11/25/2020 | OptiNose, Inc. | OPTN | Exercise | Stock Option (Right to Buy) | 3.5k | $1.63 | $5.7k | By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud | 11/23/2020 |
11/25/2020 | OptiNose, Inc. | OPTN | Payment of Exercise | Common Stock | 4k | $4.32 | $17.2k | | 11/23/2020 |
11/25/2020 | OptiNose, Inc. | OPTN | Sale | Common Stock | 977 | $4.32 | $4.2k | By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud | 11/23/2020 |
|
|